JAKAVI 15MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)

MRP: ₹51900.00

NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Jakavi 15MG Tablet, 10 tablets, salt ruxolitinib 15mg. Its MRP stays at Rs 51,900 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 39,542.86. Group: JAK1/JAK2 inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: do not stop suddenly - symptoms can rebound. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.